Aníbal Díaz
Aníbal Díaz is the dean of the Colegio Químico Farmacéutico del Perú and a recognized authority in pharmaceutical sciences. He has been actively involved in discussions regarding the safe production and regulation of medical products in Peru. Díaz gained media attention recently for highlighting the risks associated with the temporary closure of Medifarma, which produces the majority of saline solution used in healthcare facilities, raising concerns about potential shortages in the medical supply chain.
Not in the pool (under ¢1).
Recent news mentions
Deputy Aníbal Díaz claims he has a 96% attendance rate in Congress.
Diputado Aníbal Díaz asegura que tiene 96% de asistencia en el Congreso
Dominican Republic· 2026-03-05
Aníbal Díaz is the president of the Tourism Commission of the Chamber of Deputies.
Invertirán RD$600 MM en remodelación de playa Boca ChicaDominican Republic· 2025-07-07
Aníbal Díaz is a deputy who supports David Collado's political aspirations.
El proselitismo del oficialismo integra a funcionarios públicosDominican Republic· 2025-06-10
Aníbal Díaz is the spokesperson for the PRM in the Chamber of Deputies.
Las batallas internas que se libran en el PRMDominican Republic· 2025-06-01
Aníbal Díaz indicated that physiological saline is the most used product in medical practice.
Medifarma produce al menos el 70% del suero fisiológico disponible: ¿El cierre temporal de la farmaceútica generará un desabastecimiento del stock nacional? | Medifarma | Suero | Sanna| Digemid | Minsa | LIMA
Peru· 2025-03-31
